Starting HIV Treatment Quickly to Reduce Stigma in People Who Inject Drugs

This study is testing a new approach called rapid-start antiretroviral therapy (RS-ART) for people with HIV who inject drugs. The goal is to start HIV medication within 7 days of diagnosis, rather than waiting. Researchers believe that starting treatment this quickly may reduce the shame and stigma people often feel about their diagnosis and drug use, while also helping the medication work better.

Many people with HIV who inject drugs face deep stigma from healthcare providers and society, which can prevent them from seeking care or taking their medications consistently. This trial exists to see whether starting treatment very quickly—based on medical need rather than judgment about a patient's worthiness—can help break down that stigma and improve both health and quality of life.